NEW YORK (GenomeWeb News) - Fluidigm said last week that the Department of Chemical Pathology at the Chinese University of Hong Kong has licensed its BioMark real-time PCR system.
Fluidigm said that the lab is using the system to study viruses associated with cancer, to detect somatic mutations in genes, and to develop gene expression profiles, among other molecular diagnostic research projects.
Financial terms of the agreement were not provided.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.